We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

EKF Diagnostics

Manufactures analysers for the measurement of glucose, lactate, hemoglobin, hematocrit and HbA1c for GP surgeries, ph... read more Featured Products: More products

Download Mobile App




POCT Offers Cost-Effective Convenience and Improved HbA1c Analysis

By LabMedica International staff writers
Posted on 09 Jul 2013
Print article
A glycated hemoglobin (HbA1c) analyzer for near-patient monitoring of diabetes is cost-effective and easy-to-use.

Called the Quo-Test, the compact analyzer will be demonstrated by BHR at Heart UK’s annual conference in Bristol (UK), during July 2013.

A product of EKF Diagnostics (Cardiff, United Kingdom), Quo-Test provides rapid measurement of HbA1c at the point-of-care (POC). The analyzer provides lab-accurate results in only four minutes from 4 μL of venous or finger prick blood. This enables clinicians to make immediate decisions for a patient’s diabetes management and should result in improved diabetic control, better patient outcomes and enhanced clinic efficiency, with fewer patient visits, and subsequent economic benefits.

CE marked, Quo-Test is fully automated with intuitive step-by-step onscreen instructions minimizing training time. The compact analyzer also ensures efficient data handling, with a barcode reader included and storage of up to 7,000 results, which can be downloaded to a laboratory information system (LIS) via its USB port. The results are unaffected by hemoglobin variants because Quo-Test uses the boronate affinity method, which is interference free.

Andrew Greaves, BHR Sales Director, commented, “Due to the evident link between diabetes and heart disease, EKF Diagnostics’ Quo-Test is an ideal analyzer to showcase at this event [Heart UK] since it delivers easy and reliable measurement of HbA1c used for the detection and management of diabetes at the point-of-care.”

Related Links:

BHR
EKF Diagnostics


Gold Member
Rotavirus Test
Rotavirus Test - 30003 – 30073
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Centromere B Assay
Centromere B Test
New
Biological Indicator Vials
BI-O.K.

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.